{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:02:42Z","timestamp":1780045362845,"version":"3.53.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hefei Municipal Health Commission","award":["Hwk2024zd008"],"award-info":[{"award-number":["Hwk2024zd008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02321-y","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T07:05:22Z","timestamp":1779260722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Triglyceride\u2013glucose body mass index and metabolic dysfunction-associated steatotic liver disease in hospitalized patients with type 2 diabetes: a sex-stratified cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"given":"Qiao-juan","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Chuan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"issue":"6","key":"2321_CR1","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542\u201356. https:\/\/doi.org\/10.1016\/j.jhep.2023.06.003.","journal-title":"J Hepatol"},{"issue":"1","key":"2321_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384.","journal-title":"Hepatology"},{"issue":"9","key":"2321_CR3","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(9):851\u201361.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"2321_CR4","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202\u20139.","journal-title":"J Hepatol"},{"issue":"1","key":"2321_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328\u201357.","journal-title":"Hepatology"},{"issue":"9","key":"2321_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","volume":"18","author":"G Targher","year":"2021","unstructured":"Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus \u2014 mechanisms and treatments. Nat Rev Gastroenterol Hepatol. 2021;18(9):599\u2013612.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"2321_CR7","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","volume":"71","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Golabi P, de Avila L, Paik JM, Srishord M, Fukui N, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol. 2019;71(4):793\u2013801.","journal-title":"J Hepatol"},{"issue":"1 Suppl","key":"2321_CR8","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1 Suppl):S47\u201364.","journal-title":"J Hepatol"},{"key":"2321_CR9","doi-asserted-by":"publisher","first-page":"154170","DOI":"10.1016\/j.metabol.2020.154170","volume":"111S","author":"A Mantovani","year":"2020","unstructured":"Mantovani A, Scorletti E, Mosca A, Alisi A, Byrne CD, Targher G. Complications, morbidity and mortality of nonalcoholic fatty liver disease. Metabolism. 2020;111S:154170.","journal-title":"Metabolism"},{"issue":"2","key":"2321_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cmet.2007.12.009","volume":"7","author":"MS Brown","year":"2008","unstructured":"Brown MS, Goldstein JL. Selective versus total insulin resistance: a pathological distinction. Cell Metab. 2008;7(2):95\u20136.","journal-title":"Cell Metab"},{"issue":"8","key":"2321_CR11","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.2337\/db06-0200","volume":"55","author":"R Dentin","year":"2006","unstructured":"Dentin R, Benhamed F, Hainault I, Fauveau V, Foufelle F, Dyck JR, et al. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob\/ob mice. Diabetes. 2006;55(8):2159\u201370.","journal-title":"Diabetes"},{"issue":"5","key":"2321_CR12","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI23621","volume":"115","author":"KL Donnelly","year":"2005","unstructured":"Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005;115(5):1343\u201351.","journal-title":"J Clin Invest"},{"issue":"7","key":"2321_CR13","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1161\/ATVBAHA.107.160192","volume":"28","author":"M Adiels","year":"2008","unstructured":"Adiels M, Olofsson SO, Taskinen MR, Bor\u00e9n J. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008;28(7):1225\u201336.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"2321_CR14","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","volume":"52","author":"H Tilg","year":"2010","unstructured":"Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010;52(5):1836\u201346.","journal-title":"Hepatology"},{"issue":"7","key":"2321_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","volume":"13","author":"C Leung","year":"2016","unstructured":"Leung C, Rivera L, Furness JB, Angus PW. The role of the gut microbiota in NAFLD. Nat Rev Gastroenterol Hepatol. 2016;13(7):412\u201325.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"2321_CR16","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","volume":"128","author":"V Ratziu","year":"2005","unstructured":"Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology. 2005;128(7):1898\u2013906.","journal-title":"Gastroenterology"},{"issue":"3","key":"2321_CR17","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/hep.24452","volume":"54","author":"R Hernaez","year":"2011","unstructured":"Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology. 2011;54(3):1082\u201390.","journal-title":"Hepatology"},{"key":"2321_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.","journal-title":"BMC Gastroenterol"},{"issue":"7","key":"2321_CR19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"JH Lee","year":"2010","unstructured":"Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, Kim W, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42(7):503\u20138.","journal-title":"Dig Liver Dis"},{"issue":"4","key":"2321_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda LE, Rodr\u00edguez-Mor\u00e1n M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299\u2013304.","journal-title":"Metab Syndr Relat Disord"},{"issue":"7","key":"2321_CR21","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero F, Simental-Mend\u00eda LE, Gonz\u00e1lez-Ortiz M, Mart\u00ednez-Abundis E, Ramos-Zavala MG, Hern\u00e1ndez-Gonz\u00e1lez SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347\u201351.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2321_CR22","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12944-017-0613-4","volume":"16","author":"S Zheng","year":"2017","unstructured":"Zheng S, Shi S, Ren X, Han T, Li Y, Chen Y, et al. Triglyceride glucose-body mass index, a novel indicator of insulin resistance, is associated with nonalcoholic fatty liver disease in Chinese adults: a retrospective cross-sectional study. Lipids Health Dis. 2017;16(1):228.","journal-title":"Lipids Health Dis"},{"key":"2321_CR23","first-page":"862760","volume":"13","author":"Q Gu","year":"2022","unstructured":"Gu Q, Xiao J, Peng J, Gu W, Gu M, Gu W, et al. Triglyceride-glucose index and non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: a cross-sectional study. Front Endocrinol (Lausanne). 2022;13:862760.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2321_CR24","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1016\/j.diabres.2011.05.030","volume":"93","author":"AC Vasques","year":"2011","unstructured":"Vasques AC, Novaes FS, de Oliveira MS, Souza JR, Yamanaka A, Pareja JC, et al. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract. 2011;93(3):e98\u2013100.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2321_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12944-023-01879-z","volume":"22","author":"Y Wang","year":"2023","unstructured":"Wang Y, Liu B, Han H, Hu Y, Zhu L, Jiang Y, et al. Associations between triglyceride-glucose related indices and non-alcoholic fatty liver disease: a population-based study. Lipids Health Dis. 2023;22(1):111.","journal-title":"Lipids Health Dis"},{"key":"2321_CR26","first-page":"1002210","volume":"13","author":"Y Hu","year":"2022","unstructured":"Hu Y, Zhao Y, Zhao Y, Jiang Y, Wang Y, Liu B, et al. Triglyceride-glucose body mass index and non-alcoholic fatty liver disease in a Japanese population: a cross-sectional study. Front Endocrinol (Lausanne). 2022;13:1002210.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2321_CR27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12944-022-01652-8","volume":"21","author":"Y Li","year":"2022","unstructured":"Li Y, Zheng R, Li Z, Jiang X, Zhang X, Zheng J. Association of triglyceride-glucose body mass index with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: a cross-sectional study. Lipids Health Dis. 2022;21(1):45.","journal-title":"Lipids Health Dis"},{"issue":"5","key":"2321_CR28","doi-asserted-by":"publisher","first-page":"E961","DOI":"10.1152\/ajpendo.00678.2007","volume":"294","author":"K Sato","year":"2008","unstructured":"Sato K, Iemitsu M, Aizawa K, Ajisaka R. Testosterone and DHEA activate the glucose metabolism-related signaling pathway in skeletal muscle. Am J Physiol Endocrinol Metab. 2008;294(5):E961\u20138.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"2321_CR29","first-page":"261","volume":"7","author":"F Mauvais-Jarvis","year":"2011","unstructured":"Mauvais-Jarvis F. Androgen-deprivation therapy and pancreatic beta-cell function. Nat Rev Endocrinol. 2011;7(5):261\u201370.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2321_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1365-2605.2009.00953.x","volume":"33","author":"H V\u00f6lzke","year":"2010","unstructured":"V\u00f6lzke H, Aumann N, Krebs A, Nauck M, Steveling A, Lerch MM, et al. Hepatic steatosis is associated with low serum testosterone and high serum DHEAS levels in men. Int J Androl. 2010;33(1):45\u201353.","journal-title":"Int J Androl"},{"issue":"7","key":"2321_CR31","first-page":"1704","volume":"62","author":"V Jaruvongvanich","year":"2017","unstructured":"Jaruvongvanich V, Sanguankeo A, Upala S. Significant association between nonalcoholic fatty liver disease and testosterone deficiency: a systematic review and meta-analysis. Dig Dis Sci. 2017;62(7):1704\u201312.","journal-title":"Dig Dis Sci"},{"issue":"Suppl 1","key":"2321_CR32","first-page":"S1","volume":"46","author":"American Diabetes Association Professional Practice Committee","year":"2023","unstructured":"American Diabetes Association Professional Practice Committee. Standards of Medical Care in Diabetes\u20142023. Diabetes Care. 2023;46(Suppl 1):S1\u2013291.","journal-title":"Diabetes Care"},{"issue":"40","key":"2321_CR33","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.3748\/wjg.v25.i40.6053","volume":"25","author":"G Ferraioli","year":"2019","unstructured":"Ferraioli G, Soares Monteiro LB. Ultrasound-based techniques for the diagnosis of liver steatosis. World J Gastroenterol. 2019;25(40):6053\u201362.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"2321_CR34","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"7","key":"2321_CR35","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0009-9120(01)00263-6","volume":"34","author":"M Dobi\u00e1sov\u00e1","year":"2001","unstructured":"Dobi\u00e1sov\u00e1 M, Frohlich J. The plasma parameter log (TG\/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem. 2001;34(7):583\u20138.","journal-title":"Clin Biochem"},{"issue":"7","key":"2321_CR36","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911\u201330.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2321_CR37","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","volume":"58","author":"R Tibshirani","year":"1996","unstructured":"Tibshirani R. Regression shrinkage and selection via the lasso. J R Stat Soc Ser B Stat Methodol. 1996;58(1):267\u201388.","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"issue":"15","key":"2321_CR38","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1093\/jnci\/80.15.1198","volume":"80","author":"FE Harrell Jr","year":"1988","unstructured":"Harrell FE Jr, Lee KL, Pollock BG. Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst. 1988;80(15):1198\u2013202.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2321_CR39","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837\u201345.","journal-title":"Biometrics"},{"key":"2321_CR40","doi-asserted-by":"crossref","unstructured":"Pencina MJ, D\u2019Agostino RB, Sr, Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157\u201372.","DOI":"10.1002\/sim.2929"},{"issue":"6","key":"2321_CR41","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Mak. 2006;26(6):565\u201374.","journal-title":"Med Decis Mak"},{"issue":"2","key":"2321_CR42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1037\/a0031034","volume":"18","author":"L Valeri","year":"2013","unstructured":"Valeri L, Vanderweele TJ. Mediation analysis allowing for exposure-mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros. Psychol Methods. 2013;18(2):137\u201350.","journal-title":"Psychol Methods"},{"issue":"2","key":"2321_CR43","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/hep.23280","volume":"51","author":"E Fabbrini","year":"2010","unstructured":"Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010;51(2):679\u201389.","journal-title":"Hepatology"},{"issue":"4","key":"2321_CR44","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1053\/j.gastro.2012.02.003","volume":"142","author":"K Cusi","year":"2012","unstructured":"Cusi K. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology. 2012;142(4):711\u201325.","journal-title":"Gastroenterology"},{"issue":"7","key":"2321_CR45","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1373\/clinchem.2004.031757","volume":"50","author":"MH Tan","year":"2004","unstructured":"Tan MH, Johns D, Glazer NB. Pioglitazone reduces atherogenic index of plasma in patients with type 2 diabetes. Clin Chem. 2004;50(7):1184\u20138.","journal-title":"Clin Chem"},{"issue":"1","key":"2321_CR46","first-page":"64","volume":"52","author":"M Dobi\u00e1sov\u00e1","year":"2006","unstructured":"Dobi\u00e1sov\u00e1 M. AIP\u2014atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice. Vnitr Lek. 2006;52(1):64\u201371.","journal-title":"Vnitr Lek"},{"issue":"11","key":"2321_CR47","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1111\/dom.12973","volume":"19","author":"K Cusi","year":"2017","unstructured":"Cusi K, Sanyal AJ, Zhang S, Hartman ML, Bue-Valleskey JM, Hoogwerf BJ, et al. Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes. Diabetes Obes Metab. 2017;19(11):1630\u20134.","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"2321_CR48","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/hepr.12656","volume":"46","author":"S Ballestri","year":"2016","unstructured":"Ballestri S, Nascimbeni F, Romagnoli D, Lonardo A. The independent predictors of non-alcoholic steatohepatitis and its individual histological features. Hepatol Res. 2016;46(11):1074\u201387.","journal-title":"Hepatol Res"},{"issue":"4","key":"2321_CR49","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1499-3872(17)60019-5","volume":"16","author":"F Shen","year":"2017","unstructured":"Shen F, Zheng RD, Sun XQ, Ding WJ, Wang XY, Fan JG. Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease. Hepatobiliary Pancreat Dis Int. 2017;16(4):375\u201381.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"8","key":"2321_CR50","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.metabol.2015.09.017","volume":"65","author":"A Lonardo","year":"2016","unstructured":"Lonardo A, Nascimbeni F, Mantovani A, Targher G. Hypertriglyceridemia, vascular risk, atherogenic dyslipidemia, and nonalcoholic fatty liver disease. Metabolism. 2016;65(8):1092\u2013102.","journal-title":"Metabolism"},{"issue":"5","key":"2321_CR51","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/jgh.13264","volume":"31","author":"S Ballestri","year":"2016","unstructured":"Ballestri S, Zona S, Targher G, Romagnoli D, Baldelli E, Nascimbeni F, et al. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. J Gastroenterol Hepatol. 2016;31(5):936\u201344.","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"2321_CR52","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1136\/gutjnl-2020-322572","volume":"70","author":"A Mantovani","year":"2021","unstructured":"Mantovani A, Petracca G, Beatrice G, Csermely A, Lonardo A, Targher G. Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals. Gut. 2021;70(5):962\u20139.","journal-title":"Gut"},{"issue":"3","key":"2321_CR53","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","volume":"65","author":"G Targher","year":"2016","unstructured":"Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol. 2016;65(3):589\u2013600.","journal-title":"J Hepatol"},{"issue":"9","key":"2321_CR54","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/imj.14709","volume":"50","author":"TD Huang","year":"2020","unstructured":"Huang TD, Behary J, Zekry A. Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management. Intern Med J. 2020;50(9):1038\u201347.","journal-title":"Intern Med J"},{"issue":"10","key":"2321_CR55","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 2021;184(10):2537\u201364.","journal-title":"Cell"},{"issue":"3","key":"2321_CR56","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1210\/jc.2016-3580","volume":"102","author":"M Grossmann","year":"2017","unstructured":"Grossmann M, Matsumoto AM. A perspective on middle-aged and older men with functional hypogonadism: focus on holistic management. J Clin Endocrinol Metab. 2017;102(3):1067\u201375.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2321_CR57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2164\/jandrol.108.005751","volume":"30","author":"AM Traish","year":"2009","unstructured":"Traish AM, Saad F, Guay A. The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance. J Androl. 2009;30(1):23\u201332.","journal-title":"J Androl"},{"issue":"11","key":"2321_CR58","first-page":"905","volume":"8","author":"A Haider","year":"2020","unstructured":"Haider A, Haider KS, Saad F, Doros G, Hanefeld M, Dhindsa S, et al. Incidence of type 2 diabetes mellitus and its association with testosterone therapy in men with hypogonadism in Germany: an observational, real-world registry study. Lancet Diabetes Endocrinol. 2020;8(11):905\u201315.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"2321_CR59","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.2337\/dc18-2388","volume":"42","author":"A Yassin","year":"2019","unstructured":"Yassin A, Haider A, Haider KS, Caliber M, Doros G, Saad F, et al. Testosterone therapy in men with hypogonadism prevents progression from prediabetes to type 2 diabetes: eight-year data from a registry study. Diabetes Care. 2019;42(6):1104\u201311.","journal-title":"Diabetes Care"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02321-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02321-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02321-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T08:02:05Z","timestamp":1780041725000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02321-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2321"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02321-y","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"29 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was granted by the Ethics Committee of the Third People\u2019s Hospital of Hefei (Approval No. 2026LLWL024). All procedures were conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. Written informed consent was obtained from all participants prior to enrollment. Analyses were performed using anonymized clinical data collected from the study hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"165"}}